XII.r
XII - Pericardial involvement
Chylous pericardial effusion (w/wo tamponade)
Last update 17/06/2026
Back
The Drug-Induced Respiratory Disease Website
Causative drugs
1
II.a
II. Myocardial dysfunction - Heart failure
II.a Left ventricular dysfunction/failure
VI.a
VI. Cardiomyopathy
VI.a Cardiomyopathy (acute, subacute, chronic)
X.a
X. Pulmonary edema
X.a Pulmonary edema, cardiogenic
XII.b
XII. Pericardial involvement
XII.b Pericardial effusion (w/wo tamponade)
XII.r
XII. Pericardial involvement
XII.r Chylous pericardial effusion (w/wo tamponade)
XIV.a
XIV. Pleural involvement
XIV.a Pleural effusion (uni or bilateral) (can accompany ILD induced by the drug)
XVI.e
XVI. Hemorrhage - Bleeding - Hematoma(s)
XVI.e Alveolar hemorrhage (AH), diffuse AH (DAH)
XXII.b
XXII. Acute respiratory/cardiorespiratory failure
XXII.b Acute lung injury - ARDS
XXIV.a
XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis
XXIV.a Pneumonitis (ILD)
XXIV.b
XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis
XXIV.b Pneumonitis (ILD), acute and/or severe (may cause ARDS)
XXIV.c
XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis
XXIV.c Eosinophilic pneumonia (pulmonary infiltrates and eosinophilia)